![]() Promethera Biosciences Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases. | ![]() Intercept Pharmaceuticals Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases. | ![]() Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. | |
Founding Date | Founding Date 2009 | Founding Date 2002 | Founding Date 1996 |
Type | Type Subsidiary | Type Public | Type Public |
Tags | |||
Locations | Locations Mont-Saint-Guibert, BE HQ Charleroi, BE Ganshoren, BE Chuo City, JP Chuo City, JP Basel, CH Durham, US see more | Locations New York, US HQ Wien, AT Mississauga, CA Kongens Lyngby, DK Paris, FR München, DE Dublin, IE see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more |
Employees | Employees 185% decrease | Employees 58321% increase | Employees 75,883 |
Financial | |||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) $285.7m (FY, 2022) | Revenue (est.) $56.7b (FY, 2025) |
Cost of goods | Cost of goods N/A | Cost of goods $984k (FY, 2022) | Cost of goods $8.4b (FY, 2025) |
Gross profit | Gross profit N/A | Gross profit $284.7m (FY, 2022) | Gross profit $49.8b (FY, 2025) |
Net income | Net income N/A | Net income $221.8m (FY, 2022) | Net income $14b (FY, 2025) |
Funding | |||
Total funding raised | Total funding raised $ 146m | Total funding raised $ 55m | Total funding raised $ 6.5m |

Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases.
View company
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View company